Dear QSP community members, here is an opportunity to review and comment on the FDA draft docket on E-R analysis in drug development and regulatory decisions available
here.
Please feel free to review and send in your comments in this thread or directly to me. I would be happy to combine them and send on to the AAPS leaders.